Management of non-alcoholic fatty liver disease in patients with sarcopenia

Expert Opin Pharmacother. 2022 Feb;23(2):221-233. doi: 10.1080/14656566.2021.1978978. Epub 2021 Sep 20.

Abstract

Introduction: Sarcopenia usually occurs with aging, sedentary lifestyle, unhealthy dietary habits, and chronic disorders pathophysiologically and bi-directionally linked to obesity and nonalcoholic fatty liver disease (NAFLD). Because of the global increase in aging and obesity populations, patients with concomitant sarcopenia and NAFLD are common, accompanied by various disorders relevant to obesity and sarcopenia, with across-the-board impact on socio-economic and public health life worldwide. Therefore, developing effective and practical management of these patients has become a pressing clinical issue.

Areas covered: The authors searched literature from PubMed and Ovid MEDLINE up until Feb 2020. Emerging data on the management of sarcopenia and nonalcoholic fatty liver disease were examined and discussed.

Expert opinion: Although NAFLD in patients with sarcopenia has become a critical problem worldwide, we still don't know much about the management of such patients. Based on theoretical speculations, we can recommend lifestyle intervention, including diet control with adequate protein intake, exercise intervention, and weight reduction as the mainstay of management at the first stage. More studies are needed in the future to identify the most suitable treatment and solve this important problem.

Keywords: Sarcopenia; aging; exercise; feeding behavior; nonalcoholic fatty liver disease; obesity; prognosis; sedentary behavior; skeletal muscle; weight loss.

MeSH terms

  • Humans
  • Life Style
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / therapy
  • Obesity / complications
  • Obesity / therapy
  • Sarcopenia* / etiology
  • Sarcopenia* / therapy
  • Weight Loss